341 – 350 of 459
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2001
-
Mark
Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues
(
- Contribution to journal › Article
-
Mark
Measurement of circulating forms of prostate-specific antigen in whole blood immediately after venipuncture: implications for point-of-care testing
(
- Contribution to journal › Article
-
Mark
Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing
(
- Contribution to journal › Article
- 2000
-
Mark
Sensitive and specific immunodetection of human glandular kallikrein 2 in serum
(
- Contribution to journal › Article
-
Mark
Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden
(
- Contribution to journal › Article
-
Mark
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum
(
- Contribution to journal › Article
-
Mark
Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer
(
- Contribution to journal › Article
-
Mark
Studies on phenotypic expression patterns of proteases and protease inhibitors in benign compared to malignant prostate tissues
(
- Contribution to journal › Article
-
Mark
Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater
(
- Contribution to journal › Article
-
Mark
Time-resolved fluorescence imaging for quantitative histochemistry using lanthanide chelates in nanoparticles and conjugated to monoclonal antibodies
(
- Contribution to journal › Article